Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I single- and multiple-ascending doses trial of AM 125 in healthy subjects.

Trial Profile

A phase I single- and multiple-ascending doses trial of AM 125 in healthy subjects.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Oct 2018

At a glance

  • Drugs Betahistine (Primary) ; Betahistine
  • Indications Vertigo
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 17 Oct 2018 According to an Auris Medical media release, the company will host a conference call and web-cast to review the top-line results from this trial today (October 17, 2018). A live webcast of the conference call can be accessed in the Investor Relations section of the Auris Medical website at www.aurismedical.com.
    • 17 Oct 2018 Results presented in the Auris Medical media release.
    • 15 Sep 2018 According to an Auris Medical media release, dosing is approaching completion.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top